Partner Dan Shores will present on "Addressing IP challenges for RNA-based vaccine development" at the 2023 Vaccine Innovation Forum taking place June 29-30, 2023, in Beijing, China. Dan will present his session virtually.
Dan's session, taking place on the second day of the conference, June 30, will provide an in-depth discussion relating to the IP, litigation, and competitive landscape in the mRNA and lipid nanoparticle space including recent trends and related analyses.
The Vaccine Innovation Forum (VIF) will bring together more than 400 representatives from corporate executives, industry leaders, well-known scholars, relevant government departments, etc. discussing the latest developments and trends of the vaccine industry, business strategies, world-leading vaccine R&D progresses and breakthroughs, cooperation opportunities, and other latest and most cutting-edge topics. The conference aims to provide a platform for vaccine industry professionals to learn and communicate, and to promote international industry-university-research cooperation and business development.
To learn more about the event, please visit the VIF 2023 website.
